| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 502133-05-3 | | 3-(3,4,5-trimethoxyphenyl)-1h-pyrazol-5-amine | | | | |
| 502133-37-1 | | 6-ethyl-2-(1-piperazinyl)-4(3h)-pyrimidinone | | | | |
| 502133-49-5 | | 2-{4-[(tert-butoxy)carbonyl]-1,4-diazepan-1-yl}pyridine-3-carboxylic acid | | | | |
| 502133-50-8 | | 6-{4-[(tert-butoxy)carbonyl]-1,4-diazepan-1-yl}pyridine-3-carboxylic acid | | | | |
| 502133-51-9 | | 2-(1,4-diazepan-1-yl)-6-ethyl-4(3h)-pyrimidinone | | | | |
| 502133-53-1 | 1-吡嗪-2-基-1,4-二氮杂烷 | 1-pyrazin-2-yl-[1,4]diazepane | | | | |
| 502133-60-0 | | 1-(3,5-dichloropyridin-2-yl)-1,4-diazepane | | | | |
| 502133-61-1 | | 1-(6-chloro-2-pyridinyl)-1,4-diazepane | | | | |
| 502133-62-2 | | 1-(5-chloropyridin-2-yl)-1,4-diazepane | | | | |
| 502133-68-8 | 5-(四氢呋喃-2-基)-1,3,4-噁二唑-2-胺 | 5-(tetrahydrofuran-2-yl)-1,3,4-oxadiazol-2-amine | | | | |
| 502133-69-9 | 5-[(甲硫基)甲基]-1,3,4-噁二唑-2-胺 | 5-[(methylthio)methyl]-1,3,4-oxadiazol-2-amine | | | | |
| 502137-98-6 | | hdm2 e3 ligase inhibitor ii, hli373-cas 502137-98-6-calbiochem | | | | |
| 502141-03-9 | 5h-吡咯并[2,3-b]吡嗪-7-羧酸 | 5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid | | | | |
| 502141-81-3 | | (2-chloro-6-methyl-pyrimidin-4-yl)-ethyl-amine | | | | |
| 502142-36-1 | | 1-(3-methoxy-benzyl)-[1,4]diazepane | | | | |
| 502142-81-6 | 6-氨基-2,5-二氯嘧啶-4-羧酸甲酯 | methyl 6-amino-2,5-dichloropyrimidine-4-carboxylate | | | | |
| 502143-36-4 | | 3-amino-5,6-dibromopyrazine-2-carboxylic acid | | | | |
| 502144-09-4 | 3-氮杂环丁烷-1-基丙酸甲酯 | methyl 3-(azetidin-1-yl)propanoate | | | | |
| 502145-18-8 | 2-氨基-4-溴噻唑 | 2-amino-4-bromothiazole | | | | |
| 502161-03-7 | 3-碘-9-苯基咔唑 | 3-iodo-9-phenylcarbazole | | | | |
| 502169-73-5 | 四氯金(iii)酸锂水合物 | lithium tetrachloroaurate(iii) hydrate | | | | |
| 502170-49-2 | | 4-[(4-boc-amino-1-methyl-1h-imidazole-2-carbonyl)-amino]-1-methyl-1h-imidazole-2-carboxylic acid | | | | |
| 502184-51-2 | 5-氨基-2,6-二氯嘧啶-4-羧酸甲酯 | methyl 5-amino-2,6-dichloropyrimidine-4-carboxylate | | | | |
| 5022-26-4 | | n-benzyl-2,2-diphenylacetamide | | | | |
| 5022-29-7 | 2-乙基-1H-异吲哚-1,3(2H)-二酮 | 3(2H)-dione, 2-ethyl-1H-Isoindole-1 | C10H9NO2 | 175.18 | 76-78℃ | |
| 5022-48-0 | | 5-chloro-2-hydroxybenzohydrazide | | | | |
| 5022-65-1 | | l-tryptophanamide hcl | C11H13N3O.HCl | 239.70 | | |
| 5022-68-4 | | thiourea-14c | H4CsN2 | 164.95 | | |
| 5023-12-1 | | 6-methoxy-2h-benzo[b][1,4]oxazin-3(4h)-one | | | | |
| 5023-46-1 | | (4-chlorophenoxy)-acetic aci 2-(dimethylamino)-1-methylethyl ester | | | | |
| 5023-60-9 | | p-tolyl benzyl sulfide | | | | |
| 5023-61-0 | | benzyl m-tolyl sulfide | | | | |
| 5023-62-1 | | benzyl 2,5-dimethylphenyl sulfide | | | | |
| 5023-65-4 | | 4-methylbenzyl phenyl sulfide | | | | |
| 5023-94-9 | | N-HYDROXY-3-NITROBENZENE CARBOXIMIDAMIDE 95% | | | | |
| 5024-21-5 | 十四烯二酸二甲酯 | Tetradecanedioic acid, dimethyl ester | C16H30O4 | 286.41 | | |
| 5024-84-0 | 1,4-双(3-甲氧基苯氧基)苯 | 1,4-bis(3-methoxyphenoxy)benzene | | | | |
| 502421-44-5 | | valaciclovir impurity s | | | | |
| 502424-52-4 | | tert-butyl b-oxo-4-fluoro-benzenepropanoate | | | | |
| 502424-53-5 | | tert-butyl 4-trifluoromethylbenzoylacetate | | | | |
| 502435-32-7 | | 2-fluoro-n,4-dimethylbenzenamine | | | | |
| 502457-67-2 | | 4-(3-fluorophenyl)phenylmagnesium bromide, 0.25m thf | | | | |
| 502461-98-5 | | 5-methoxypyridin-3-ylmagnesium bromide, 0.25m thf | | | | |
| 502467-23-4 | 9-(2-羧基苯基)-2-氯-5-[{2-(二(2-吡啶基)氨基甲基)苯基}氨基甲基]-6-羟基-3-黄原胶酮 | 9-(2-carboxyphenyl)-2-chloro-5-[{2-(di(2-pyridyl)aminomethyl)phenyl}aminomethyl]-6-hydroxy-3-xanthanone zinpyr-4 | | | | |
| 502481-30-3 | 3,5-二硝基-l-酪氨酸钠盐 | 3,5-dinitro-l-tyrosine sodium salt | | | | |
| 502482-52-2 | | 2-(1-(tert-butoxycarbonyl)-4-hydroxypiperidin-4-yl)acetic acid | | | | |
| 502483-45-6 | | 4-(trifluoromethoxy)benzhydrol | | | | |
| 502483-46-7 | | 3,4-dichlorophenyl-(2-pyridyl)methanol | | | | |
| 502486-45-5 | | 6-nitro-[1,2,4]triazolo[4,3-a]pyridine | | | | |
| 502486-89-7 | | nida-41020 | | | | |
m.cnreagent.com